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Abstract 
Background: A key role for HIF‑1α in the promotion and maintenance of dietary obesity has been proposed. We 
analyzed the association between hypoxia and de novo lipogenesis in human adipose tissue.
Methods: We studied HIF‑1α mRNA and protein expression in fasting status in visceral adipose tissue (VAT) from 
non‑obese and morbidly obese subjects, and in VAT from wild‑type and ob/ob C57BL6J mice in both fasting and 
feeding status. We also analyzed the effect of hypoxia on the VAT mRNA expression of genes involved in lipogenesis.
Results: HIF‑1α was increased in VAT from morbidly obese subjects. In fasting status, C57BL6J ob/ob mice had a 
higher VAT HIF‑1α mRNA expression than C57BL6J wild‑type mice. In feeding status, VAT HIF‑1α mRNA expression 
significantly increased in C57BL6J wild‑type, but not in C57BL6J ob/ob mice. In humans, HIF‑1α mRNA expression 
correlated positively with body mass index and insulin resistance. VAT HIF‑1α mRNA expression correlated negatively 
with ACC1, PDHB and SIRT3 mRNA expression, and positively with PPAR‑γ. VAT explants incubated in hypoxia showed 
reduced SIRT3 and increased PPAR‑γ, SREBP‑1c, ACLY, ACC1 and FASN mRNA expression.
Conclusions: Morbidly obese subjects have a higher level of VAT HIF‑1α. Postprandial status is associated with 
an increase in HIF‑1α mRNA expression in C57BL6J wild‑type mice. Hypoxia alters the mRNA expression of genes 
involved in de novo lipogenesis in human VAT.
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Background
Hypoxia has been involved in the pathogenesis of sev-
eral human diseases [1]. Hypoxia mainly mediates its 
effect through the activation of hypoxia-inducible factor 
(HIF), a transcription factor composed of two subunits, 
HIF-1α and β. HIF-1β is constitutively expressed and 
not regulated directly by O2 [2]. There are at least three 
α-subunits of HIF-1, HIF-1α, HIF-2α and HIF-3α, and 
the combination of any of these with HIF-1β forms the 
functional transcription factor. HIF-1α appears to be the 
most important. In hypoxia, there is no degradation of 
HIF-1, and stabilized HIF-1 protein translocates to the 
nucleus and modifies the transcription of different genes 
[3].
The correct function of adipose tissue is of vital impor-
tance to avoid different obesity-associated disorders [4, 
5]. Moreover, a previous study has shown that the status 
of different pathways involved in fatty acid metabolism 
may be involved in the improvement of morbidly obese 
subjects after bariatric surgery [6]. Hypoxia affects a 
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proliferation, apoptosis, inflammation and insulin resist-
ance [7, 8]. Different studies suggest that adipose tissue 
is poorly oxygenated in obese humans and mice, result-
ing in the induction of HIF-1α [5, 9]. In most studies in 
obese people, fasting subcutaneous adipose tissue blood 
flow (ATBF) is reduced compared with lean people [10]. 
Also, ATBF increases rapidly after a meal [11], but this 
response to meal ingestion is diminished, or lost entirely, 
in obese people [10]. However, little information is avail-
able on its postprandial effect on human visceral adipose 
tissue (VAT) hypoxia. This issue could be important 
since humans are in a feeding status most of the day. In 
addition, there is a close association between VAT oxy-
genation status and the development of obesity [12]. The 
postprandial ATBF response has also been shown to be 
related to insulin sensitivity, independent of body mass 
index (BMI) [13]. Other studies also suggest that adipose 
tissue plays an important role in the development of insu-
lin resistance [14]. A direct effect of hypoxia in inducing 
insulin resistance in 3T3-L1 adipocytes has been docu-
mented [15].
Some studies have related hypoxia to the expression of 
genes associated with lipid metabolism, such as peroxi-
some proliferator-activated receptor-gamma (PPAR-γ) 
and sterol regulatory element-binding proteins-1c 
(SREBP-1c) [16]. A key role for HIF-1α has been pro-
posed in the promotion and maintenance of dietary 
obesity, at least in part, by suppressing adipocyte lipid 
catabolism [17]. However, most of these studies were 
conducted in rodents and in tissues different to adipose 
tissue. There is very little reported on the influence of 
hypoxia on de novo lipogenesis in human VAT. Different 
genes involved in this pathway could be modified in the 
hypoxia condition, such as ATP citrate lyase (ACLY) (cat-
alyzes the synthesis of cytosolic acetyl-CoA from citrate) 
[18], acyl-CoA synthetase short-chain family member 2 
(ACSS2) (catalyzes the activation of cytosolic acetate to 
acetyl-CoA) [19], pyruvate dehydrogenase (lipoamide) 
beta (PDHB) (converts pyruvate into acetyl-CoA in mito-
chondria) [20], acetyl-CoA carboxylase-α (ACC1) (cata-
lyzes the carboxylation of acetyl-CoA to malonyl-CoA) 
[21] and fatty acid synthase (FASN) (catalyzes the con-
densation of acetyl-CoA and malonyl-CoA to produce 
palmitic acid) [22]. Also, sirtuin-3 (SIRT3) has been pro-
posed as a major control point for obesity-related meta-
bolic diseases and it can regulate the activity of some of 
these genes [23].
Since hypoxia could be related to adipocyte lipid syn-
thesis, we studied the relationship between HIF-1α, a 
marker of hypoxia, and the mRNA expression of genes 
involved in lipogenesis in human VAT. First, in the pre-
sent study we analyzed the association between VAT 
HIF-1α and several obesity-related variables and the 
mRNA expression of genes involved in lipogenesis. Since 
in previous studies we have demonstrated that insulin 
resistance was associated with the expression of genes 
involved in lipid metabolism and with other proteins in 
adipose tissue [24–28], we wanted to determine whether 
insulin resistance is also associated with HIF-1α. Second, 
we tested in  vitro the effect of hypoxia on the mRNA 
expression of genes involved in lipogenesis. We have 
performed this study in VAT since there is a close associ-
ation between the VAT oxygenation status and the devel-
opment of obesity [12]. Also, a recent study has shown 
that although delivery of O2 to the obese subcutaneous 
adipose tissue (SAT) is reduced, no evidence of a meta-
bolic signature is found to support the notion of obesity-
related SAT hypoxia in the fasting and postprandial states 
[29]. Third, as humans are in a feeding status most of the 
day [30], we tested whether this state produces a change 
in VAT HIF-1α expression. There is little information on 
the effect of the postprandial state on HIF-1α expres-
sion in human VAT. However, given the impossibility 
of access to human VAT in the postprandial state, we 
used C57BL6J mice to test whether this state produces a 




We evaluated 30 morbidly obese subjects, 15 with low 
insulin resistance [homeostasis model assessment of 
insulin resistance index (HOMA-IR) <4.7] and 15 with 
high insulin resistance (HOMA-IR >8) [24]. All the mor-
bidly obese subjects underwent biliopancreatic diver-
sion of Scopinaro. We also studied 15 non-obese subjects 
who underwent laparoscopic surgery for cholelithiasis. 
Subjects were excluded if they were receiving insulin or 
hypoglycemic agents, had cardiovascular disease, arthri-
tis, acute inflammatory disease, infectious disease, or 
were receiving drugs that could alter the lipid profile or 
the metabolic parameters at the time of inclusion in the 
study. All subjects were of Caucasian origin. All partici-
pants gave their written informed consent and the study 
was reviewed and approved by the Ethics and Research 
Committee of Virgen de la Victoria Clinical University 
Hospital, Malaga, Spain.
Laboratory measurements
Blood samples were collected after a 12-h fast. The serum 
was separated and immediately frozen at −80 °C. Serum 
biochemical parameters were measured in duplicate. 
Serum glucose, cholesterol, triglycerides and free fatty 
acids (FFA) were measured by standard enzymatic meth-
ods (Randox Laboratories Ltd., Antrium, UK). Total adi-
ponectin levels were measured by enzyme immunoassay 
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(ELISA) kits (DRG Diagnostics, Marburg, Germany). 
Leptin levels were measured by ELISA kit from Mediag-
nost (Reutlingen, Germany). The insulin was analyzed by 
an immunoradiometric assay (BioSource International, 
Camarillo, CA). The HOMA-IR was calculated from 
fasting insulin and glucose: HOMA-IR =  fasting insulin 
(μIU/mL) × fasting glucose (mol/L)/22.5.
Human adipose tissue samples
All reagents were from Sigma-Aldrich (Sigma-Aldrich, 
St. Louis, MO) unless otherwise indicated. VAT samples 
were obtained during bariatric surgery in the morbidly 
obese subjects (n = 30) and during laparoscopic surgery 
in the non-obese subjects (n  =  15) [6, 24, 25]. Biopsy 
samples were immediately washed in physiological saline 
and frozen in liquid nitrogen after being obtained from 
the subject, and then stored at −80  °C until analysis. 
Another VAT sample from the non-obese subjects was 
placed in phosphate buffered saline (PBS) supplemented 
with 5  % bovine serum albumin (BSA) to perform adi-
pose tissue explant cultures.
Human adipose tissue culture
VAT explants from non-obese subjects were prepared by 
cutting samples into 5  mg portions, which were subse-
quently incubated for 30 min in PBS + 5 % BSA (3 ml/g) 
[26]. After 30  s of centrifugation (400g), samples were 
incubated in M199 medium (Life Technologies, Grand 
Island, NY) supplemented with 10 % fetal bovine serum 
(FBS), 100  U/mL penicillin and streptomycin. VAT 
explants were incubated for 24 h at 37 °C in 95 % air and 
5  % CO2 (normoxic conditions) or placed in a hypoxic 
chamber (Billups-Rothenberg, Dell Mar, CA) at 37  °C 
and 1 % O2, 5 % CO2, and 94 % N2 (hypoxic conditions) 
(n = 5). Following these treatments, VAT explants were 
immediately collected and frozen in liquid nitrogen, and 
then stored at −80 °C until analysis.
Animal study
Thirty-four C57BL6J wild-type mice and the same num-
ber of C57BL6J ob/ob mice (body weight 18.7 ± 1.8 and 
37.5 ±  2.5 g, respectively) were used. The animals were 
obtained from the animal care facility of Malaga Univer-
sity and were housed under constant temperature condi-
tions (20–25 °C) and day length 12 h. C57BL6J wild-type 
mice and C57BL6J ob/ob mice were randomly divided 
into two groups: one group of mice was fed ad  libitum 
and the other group was withheld food for 24  h before 
being sacrificed. All groups were allowed access to tap 
water ad  libitum. The experimental procedures for ani-
mal use and care were in accordance with the European 
Community Council Directive 86/609/EEC. Protocols 
were approved by the Bioethical Committee of Virgen de 
la Victoria Clinical University Hospital, Malaga, Spain. 
Animals were sacrificed by decapitation and VAT biop-
sies were immediately frozen in liquid nitrogen and then 
stored at −80 °C for gene expression analysis.
RNA extraction and real‑time quantitative PCR
Frozen VAT from human, mice and explant cultures was 
introduced in Trizol (QIAGEN Science, Hilden, Ger-
many), thawed and immediately homogenized with an 
Ultra-Turrax 8 (Ika, Staufen, Germany). Total RNA was 
obtained by RNeasy lipid tissue midi kit (QIAGEN Sci-
ence, Hilden, Germany) as previously described [6, 27]. 
Total RNA was reverse transcribed to cDNA by using 
a high-capacity cDNA reverse transcription kit with 
RNase inhibitor (Applied Biosystems, Foster City, CA). 
The cDNA was used for quantitative real-time PCR 
in an ABI 7500 Fast Real-Time PCR System (Applied 
Biosystems, Foster City, CA). Reactions were carried 
out in duplicate for all genes using specific TaqMan® 
Gene Expression Assays (Applied Biosystems, Foster 
City, CA): mouse HIF-1α (Mm00468869_m1, RefSeq. 
NM_010431.2), and human PPAR-γ (Hs01115510_m1, 
RefSeq. NM_015869.4), SREBP-1c (Hs00967385_
g1, RefSeq. NM_001018067.1, NM_001018068.1, 
NM_001018069.1, NM_015640.3), HIF-1α (Hs00153153_
m1, RefSeq. NM_001243084.1, NM_001530.3, 
NM_181054.2), PDHB (Hs00168650_m1, RefSeq. 
NM_000925.3, NM_001173468.1, NM_033384.1), 
SIRT3 (Hs00202030_m1, RefSeq. NM_001017524.2, 
NM_012239.5), ACLY (Hs00982738_m1, RefSeq. 
NM_001096.2, NM_198830.1), ACC1 (Hs00167385_m1, 
RefSeq. NM_198834.1, NM_198836.1, NM_198837.1, 
NM_198838.1, NM_198838.1), ACSS2 (Hs00218766_
m1, RefSeq. NM_001076552.2, NM_001242393.1, 
NM_018677.3) and FASN (Hs00188012_m1, RefSeq. 
NM_004104.4). The cycle threshold (Ct) value for each 
sample was normalized with the expression of cyclophi-
lin A (PPIA) (4326316E, RefSeq. NM_021130.3). SDS 
software 2.3 and RQ Manager 1.2 (Applied Biosystems, 
Foster City, CA) were used to analyze the results with the 
comparative Ct method (2−ΔΔCt). All data were expressed 
as an n-fold difference relative to the calibrator (a mix-
ture of the SAT and VAT tissues was used as the calibra-
tor sample).
Western blot
Frozen VAT from humans and mice was thawed and 
immediately homogenized in RIPA buffer with Protease 
Inhibitor Cocktail (Sigma-Aldrich, St. Louis, MO) and 
centrifuged (13,000 rpm, 10 min, 4 °C) [28]. The concen-
tration of proteins in the supernatant was determined 
according to the bicinchoninic acid method (Thermo 
Fisher Scientific Inc. Rockford, IL). 20 μg of protein was 
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submitted to 10  % sodium dodecyl sulfate polyacryla-
mide gel electrophoresis, transferred to polyvinylidene 
difluoride membrane at 15  V for 1  h, and blocked 
in Protein-Free Tween 20 Blocking Buffer (Thermo 
Fisher Scientific Inc., Rockford, IL). After washing with 
PBS + 0.05 % Tween 20, membranes were incubated with 
a rabbit polyclonal antibody anti-HIF-1α (Santa Cruz 
Biotechnology, Santa Cruz, CA) or anti-β-actin (Sigma-
Aldrich, St. Louis, MO) at a dilution of 1:800 or 1:1000, 
respectively, for 1  h at room temperature. Membranes 
were washed and incubated with horseradish peroxidase-
conjugated secondary antibody (Promega, Madison, WI, 
USA) at a dilution of 1:1000 or 1:5000, respectively, for 
1  h at room temperature. The proteins were visualized 
with SuperSignal® West Pico Chemiluminescent Sub-
strate (Pierce Biotechnology) and quantified by an Auto-
Chemi System (UVP, Upland, CA, USA) and the image 
acquisition analysis software Labworks 4.6 (UVP). The 
results were expressed as HIF-1α/β-actin ratio.
Enzymatic assays in human adipose tissue
All reagents were from Sigma-Aldrich (Sigma-Aldrich, 
St. Louis, MO) unless otherwise specified. Fresh biopsies 
of VAT from morbidly obese (n = 5) and non-obese sub-
jects (n = 5), and VAT explant cultures from non-obese 
subjects (in normoxic and hypoxic conditions) (n  =  3) 
were immediately washed with phosphate-buffered 
saline and homogenized in RIPA buffer on ice. The cell 
lysates were sonicated briefly followed by centrifugation 
(16,000g, 4 °C) for 15 min to remove insoluble materials 
and fat. The supernatant was used to analyze the PDH, 
ACLY and ACSS enzymatic activities.
PDH activity was determined using a protocol as pre-
viously described [31]. Briefly, 4 μl of supernatant of cell 
lysate was mixed with a buffer containing 87 mM trietha-
nolamine/HCl pH 7.8, 2.0  mM MgCl2, 0.2  mM thiamin 
diphosphate, 5.0  mM pyruvate and 0.2  mM 2,6-dichlo-
rophenolindophenol in a final volume of 0.2  ml. The 
absorption change for 5 min was pursued at 600 nm and 
30 °C. Data are expressed as U/mg adipose tissue.
ACSS activity was determined using a protocol as 
previously described [32]. Briefly, 40  μl of supernatant 
of cell lysate was mixed with 140  μl of buffer contain-
ing 70 μl of 100 mM Tris–HCl buffer (pH 7.8), 10 μl of 
50 mM l-malate, 10 μl of 20 mM ATP, 10 μl of 50 mM 
MgCl2, 10 μl of 2 mM Coenzyme A trilithium salt, 10 μl 
of 60 mM NAD+, 10 μl of 50 U/ml malate dehydrogenase 
from bovine heart and 10 μl of 25 U/ml citrate synthase 
from porcine heart. The reaction was started by adding 
of 20  μl of 1  M sodium acetate, incubated at 37  °C and 
the absorbance monitored at 340 nm for 10 min. Data are 
expressed as U/mg adipose tissue.
ACLY activity was determined using a protocol as 
previously described [33]. Briefly, 10  μl of supernatant 
of cell lysate was mixed with 290 μl of a buffer contain-
ing 96  mM triethanolamine, 0.5  mM zinc chloride, 
0.23  mM β-NADH, 0.67  mM sodium citrate, 100 units 
l-lactic dehydrogenase, 50 units malic dehydrogenase 
and 15 mM ammonium sulfate, pH 7.6. The reaction was 
monitored at 340  nm for 5  min at room temperature. 
Data are expressed as U/mg adipose tissue.
Malonyl‑CoA in human adipose tissue
Malonyl-CoA concentration was analyzed by a com-
mercial kit (BlueGene Biotech, Shanghai, China) in fresh 
biopsies of VAT from morbidly obese (n =  5) and non-
obese subjects (n = 5), and in VAT explant cultures from 
non-obese subjects (in normoxic and hypoxic conditions) 
(n = 3) according to manufacturer’s instructions.
Statistical analysis
The statistical analysis was done with SPSS (Version 11.5 
for Windows; SPSS, Chicago, IL). Differences between 
the two groups were compared by the Student t test. 
Comparison between the results of the different groups 
was done with a univariate general linear model, adjusted 
for sex, and the post hoc analysis was done with the Bon-
ferroni method. The Pearson correlation coefficients 
were calculated to estimate the correlations between 
variables. Multiple linear regressions were used to deter-
mine the association between HIF-1α mRNA expression 
and other variables. Values were considered to be statisti-
cally significant when P ≤ 0.05. The results are given as 
the mean ± SD, and as the mean ± SEM in figures.
Results
HIF‑1α was increased in morbidly obese subjects
Table  1 summarizes the characteristics of the different 
groups of subjects. HIF-1α mRNA expression in VAT 
was increased in the morbidly obese subjects (Fig.  1a). 
These results were confirmed by western blot analysis 
(n = 4 per group) (Fig. 1b).
HIF‑1α was associated with biochemical 
and anthropometric variables
HIF-1α mRNA expression in VAT correlated positively 
with different anthropometric variables, such as weight 
(r = 0.676, p < 0.001), BMI (r = 0.514, p = 0.001), waist 
(r = 0.602, p < 0.001) and hip circumferences (r = 0.470, 
p =  0.004), insulin (r =  0.470, p =  0.004) and HOMA-
IR (r  =  0.449, p  =  0.008). HIF-1α mRNA expres-
sion in VAT correlated negatively with adiponectin 
(r = −0.418, p = 0.019). The variable which was associ-
ated with VAT HIF-1α mRNA expression in a multiple 
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linear regression model was the HOMA-IR (β =  2.022, 
p = 0.047) (R2 = 0.242), after adjusting for sex, age, BMI, 
waist and hip circumferences, insulin and adiponectin.
HIF‑1α expression was associated with the expression 
of genes involved in de novo lipogenesis in human adipose 
tissue
Table 2 shows the expression of different genes involved 
in de novo lipogenesis in human VAT (PPAR-γ, SREBP-
1c, ACLY, ACSS2, PDHB, ACC1, FASN and SIRT3). 
Morbidly obese subjects had a lower mRNA expression 
of SREBP-1c, ACLY, ACSS2, PDHB, ACC1 and FASN 
than non-obese subjects. The measure of the enzy-
matic activity confirmed the results of mRNA expres-
sion of ACLY (non-obese: 0.033  ±  0.002 vs. morbidly 
obese subjects: 0.021  ±  0.005  U/mg VAT, p  =  0.026), 
ACCS (non-obese: 0.025  ±  0.017 vs. morbidly obese 
subjects: 0.007 ± 0.003 U/mg VAT, p = 0.016) and PDH 
(non-obese: 4.3  ×  10−8  ±  0.20  ×  10−8 vs. morbidly 
obese subjects: 1.1  ×  10−8  ±  0.3  ×  10−8  U/mg VAT, 
p  =  0.048). ACC1 mRNA expression was confirmed 
by the analysis of malonyl-CoA concentration in VAT 
(non-obese: 0.126  ±  0.055 vs. morbidly obese subjects: 
0.074 ± 0.025 ng/mg VAT, p = 0.048).
We found a significant correlation between HIF-1α 
mRNA expression and ACC1 (r  =  −0.417, p  =  0.009), 
SIRT3 (r  =  −0.346, p  =  0.039), PDHB (r  =  −0.585, 
p  =  0.037) and PPAR-γ mRNA expression (r  =  0.395, 
p = 0.014).
Hypoxia altered de novo lipogenic gene expression
Hypoxia produced a significant reduction in the 
mRNA expression of SIRT3 (p =  0.033) (Fig.  2). How-
ever, hypoxia produced a significant increase in ACC1 
(p  =  0.011), ACLY (p  =  0.020), PPAR-γ (p  =  0.017), 
FASN (p  =  0.011) and SREBP-1c mRNA expression 
(p  =  0.034). The measure of the enzymatic activity 
Table 1 Anthropometric and  biochemical variables in  the 
non-obese and morbidly obese subjects classified accord-
ing to their insulin resistance levels
The results are given as the mean ± standard deviation
MO-low-IR morbidly obese subjects with low insulin resistance, MO-high-IR 
morbidly obese subjects with high insulin resistance, BMI body mass index, 
HOMA-IR homeostasis model assessment of insulin resistance index
a P < 0.05 significant differences with respect to the non‑obese group
* P < 0.05 significant differences between morbidly obese patients with low and 








Sex (male/female) 4/11 5/10 5/10
Age (years) 40.3 ± 11.8 40.6 ± 11.4 37.2 ± 9.4
Weight (kg) 63.1 ± 8.5 153.6 ± 29.5a 158.7 ± 23.0a
BMI (kg/m2) 22.5 ± 1.7 55.6 ± 7.2a 57.6 ± 4.8a
Waist (cm) 80.0 ± 8.7 140.8 ± 20.3a 147.5 ± 19.6a
Hip (cm) 91.3 ± 7.7 160.1 ± 15.8a 158.1 ± 13.8a
Glucose (mg/dl) 83.1 ± 10.7 91.1 ± 10.5a 107.9 ± 15.8a*
Cholesterol (mg/
dl)
192.0 ± 42.6 201.4 ± 40.4 193.5 ± 31.3
Triglycerides (mg/
dl)
89.6 ± 44.9 114.7 ± 55.4 163.7 ± 77.8a*
Free fatty acids 
(mmol/L)
0.305 ± 0.030 0.585 ± 0.066a 0.584 ± 0.042a
Insulin (μIU/ml) 5.9 ± 3.6 12.6 ± 4.1a 39.6 ± 10.4a*
HOMA‑IR 1.2 ± 0.72 2.8 ± 0.81a 10.6 ± 2.4a*
Adiponectin (μg/
mL)
29.8 ± 18.5 10.9 ± 4.0a 8.0 ± 4.7a

































































Fig. 1 HIF‑1α expression in visceral adipose tissue (VAT) in non‑
obese and morbidly obese subjects with low (MO‑low‑IR) and high 
insulin resistance (MO‑high‑IR) in fasting condition. a HIF‑1α mRNA 
and b representative immunoblot from non‑obese and morbidly 
obese subjects (n = 4 per group). The results are given as the 
mean ± SEM. aP < 0.05 significant differences respect to the non‑
obese group. A.U. arbitrary units
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confirmed the results of mRNA expression of ACLY 
(hypoxia: 0.064 ± 0.005 vs. normoxia: 0.029 ± 0.003 U/
mg VAT, p  =  0.002), ACCS (hypoxia: 0.0081  ±  0.0007 
vs. normoxia: 0.0071  ±  0.0008  U/mg VAT, p  =  0.186) 
and PDH (hypoxia: 1.4 ×  10−8 ±  0.50 ×  10−8 vs. nor-
moxia: 1.6 ×  10−8±1.0 ×  10−8  U/mg VAT, p =  0.480). 
The ACC1 mRNA expression was confirmed by the 
analysis of malonyl-CoA concentration in VAT (hypoxia: 
0.127 ± 0.010 vs. normoxia: 0.085 ± 0.003 ng/mg VAT, 
p = 0.012).
Feeding status was associated with an increase of HIF‑1α 
in visceral adipose tissue from C57BL6J mice
As humans are in a feeding status most of the day, we 
wanted to test whether this state produces a change in 
HIF-1α mRNA expression. We used C57BL6J wild-type 
mice and obese C57BL6J ob/ob mice, given the impos-
sibility of accessing human VAT in a feeding status. In 
the fasting status, the behavior of VAT HIF-1α mRNA 
expression in C57BL6J mice was similar to human VAT. 
In fasting status, C57BL6J ob/ob mice had a higher 
HIF-1α mRNA expression than C57BL6J wild-type mice 
(p  <  0.001) (Fig.  3a). In feeding status, C57BL6J wild-
type mice had a similar HIF-1α mRNA expression than 
C57BL6J ob/ob mice (p = 0.091) (Fig. 3a). C57BL6J wild-
type mice showed a significant increase in the expression 
of HIF-1α mRNA expression in feeding status respect 
to fasting status (p < 0.0001), and C57BL6J ob/ob mice 
did not show a significant change in the expression of 
HIF-1α mRNA expression in feeding status respect to 
fasting status (p  =  0.535) (Fig.  3b). These results were 
confirmed by western blot analysis (n  =  4 per group) 
(Fig. 3b).
Discussion
This study shows that (a) VAT from morbidly obese sub-
jects has a higher level of HIF-1α, (b) hypoxia alters the 
mRNA expression of genes involved in de novo lipogen-
esis in VAT, and (c) the postprandial status is associated 
with an increase in HIF-1α in VAT from C57BL6J wild-
type mice.
Table 2 mRNA expression of  different genes involved 
in de novo lipogenesis in human visceral adipose tissue
MO-low-IR morbidly obese subjects with low insulin resistance, MO-high-IR 
morbidly obese subjects with high insulin resistance
a P < 0.05 significant differences with respect to the non‑obese group
* P < 0.05 significant differences between morbidly obese patients with low and 










SIRT3 0.029 ± 0.014 0.021 ± 0.015 0.009 ± 0.006a*
PDHB 0.460 ± 0.170 0.244 ± 0.066a 0.248 ± 0.081a
ACC1 1.87 ± 0.43 1.15 ± 0.52a 0.91 ± 0.59a
ACSS2 1.14 ± 0.29 0.78 ± 0.42a 0.80 ± 0.39a
ACLY 1.01 ± 0.79 0.42 ± 0.08a 0.31 ± 0.06a
PPARγ 1.12 ± 0.65 2.72 ± 1.89a 2.51 ± 0.87a
SREBP‑1c 0.271 ± 0.172 0.131 ± 0.072a 0.116 ± 0.067a






































Fig. 2 mRNA expression of SIRT3, PPAR‑γ, SREBP‑1c, ACLY, FASN, ACC1, ACSS2 and PDHB in visceral adipose tissue explants culture incubated for 
24 h at 37 °C in normoxic conditions (filled square) or placed in a hypoxic chamber for 24 h at 37 °C in hypoxic conditions (open square) (n = 5 per 
group). Results are shown as a percentage of the normoxic condition. The results are given as the mean ± SEM. *P < 0.05 significant differences 
between normoxic and hypoxic condition
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HIF-1α, the major hypoxia-responsive gene, was 
increased in adipose tissue from morbidly obese sub-
jects and obese mice, as in previous studies [5, 34]. This 
is in agreement with a study showing that adipose tissue 
is poorly oxygenated in obesity [35]. However, we do not 
have other techniques available in our laboratory to study 
VAT oxygenation, such as blood oxygen level-dependent 
magnetic resonance imaging, or staining with the chemi-
cal marker pimonidazole [10]. We also observed an asso-
ciation between human HIF-1α mRNA expression in 
human adipose tissue and HOMA-IR. In this respect, 
transgenic mice with constitutive activation of adipose 
HIF-1α developed insulin resistance and glucose intol-
erance [36]. In another study, hypoxia attenuated the 
insulin-stimulated glucose transport in mouse adipocytes 
[15]. Overall, our results suggest that VAT HIF-1α mRNA 
expression could be associated with the pathogenesis of 
insulin resistance.
A possible pathway that can be altered in the hypoxic 
condition is de novo lipogenesis. Reduced oxygenation of 
adipose tissue in obese humans has been associated with 
impaired insulin suppression of lipolysis [35]. PPAR-γ, 
the nuclear receptor involved in the regulation of lipid 
metabolism [37], is overexpressed in the adipose tissue of 
morbidly obese subjects [24]. Its association with hypoxia 
was confirmed in VAT explant cultures under hypoxic 
conditions, where increased PPAR-γ mRNA expression 
was found. However, opposite results were found with 
SREBP-1c [22, 38]. Our results in human VAT showed 
a decrease in SREBP-1c mRNA expression in morbidly 
obese subjects, in whom HIF-1α is increased. However, 
as in another study [38], increased SREBP-1c mRNA 
expression was found in VAT explant culture under 
hypoxic conditions. We do not know the reason for this 
discrepancy between the in vivo and in vitro results, but 
the n-6 polyunsaturated fatty acids could be involved, 
as they were increased in  vivo in morbidly obese sub-
jects [25] down-regulating the SREBP-1c expression [39, 
40]. However, in the in  vitro experiment, the fatty acid 
composition was similar in both normoxic and hypoxic 
conditions, and the effects produced by different fatty 
acids may be removed, with only the effects produced by 
hypoxia remaining.
Previous studies have shown that HIF-1α protein accu-
mulation results in an energetic uncoupling via transcrip-
tional repression of sirtuins [17]. We showed that SIRT3 
mRNA expression is decreased in VAT from morbidly 
obese subjects and in the in vitro experiment in hypoxia. 
Low levels of SIRT3 could have important effects on the 
activity of other enzymes involved in de novo lipogenesis, 
since SIRT3 activates PDHB, ACSS2 and ACC1 by dea-
cetylation [41].
The results obtained with VAT suggest a decrease in 
acetyl-CoA (a lower PDHB, ACSS2 and ACLY mRNA 
expression and enzymatic activity) and fatty acid syn-
thesis (a lower ACC1 and FASN mRNA expression and 
malonyl-CoA concentration) in morbidly obese sub-
jects. However, ACLY, ACC1 and FASN mRNA expres-
sion, ACLY activity and malonyl-CoA concentration was 
increased in the in  vitro experiment in hypoxic condi-
tions. We do not know the reason for the discrepancy 
between the in vivo and the in vitro results, but SREBP-
1c could be involved. SREBP-1c is a transcription fac-
tor involved in the up-regulation of ACLY [42], ACC1 
[43] and FASN mRNA levels [22, 40, 44]. SREBP-1c 
mRNA expression was decreased in VAT but increased 
in the in  vitro experiment in hypoxic conditions, and 
this increase could perhaps be involved in the up-regu-
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Fig. 3 HIF‑1α expression in visceral adipose tissue from wild‑type 
C57BL6J (WT) and ob/ob C57BL6J mice (Ob/Ob) in fasting (filled 
square) (n = 17 in WT and n = 17 in Ob/Ob mice) and feeding status 
(open square) (n = 17 in WT and n = 17 in Ob/Ob mice). a HIF‑1α 
mRNA and b representative immunoblot (n = 4 per group). The 
results are given as the mean ± SEM. A.U. arbitrary units
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43]. On the other hand, an increase in cytosolic citrate in 
hypoxia has been shown [45], and this could also increase 
the ACLY mRNA expression or activity, as we found. 
This would produce an increase in acetyl-CoA, the main 
precursor of fatty acid and mevalonate synthesis. Con-
sequently, a high synthesis of acetyl-CoA from other 
enzymes, such as PDHB and ACCS2, would not be neces-
sary. High levels of PDHB and ACSS2 should not be nec-
essary, as we found. Although PDHB and ACSS2 mRNA 
expression is decreased in VAT from morbidly obese sub-
jects, in whom HIF-1α is increased, 24 h hypoxia was not 
sufficient to significantly decrease the ACSS2 and PDHB 
mRNA expression or activity, as found in the in  vitro 
experiment. However, the behavior of these enzymes in 
other lipogenic tissues may be different. A limitation of 
this study is that de novo lipogenesis was not directly 
measured by other techniques, such as 3H-water incor-
poration. Also, many of these enzymes are regulated by 
post-translational events.
Another important finding of this study is that the 
behaviour of obese mice was different to that of wild-
type mice. As in morbidly obese subjects, VAT HIF-1α 
mRNA expression in obese mice was increased in the 
fasting status. In addition to hypoxia, this could be due 
to the more severe hyperinsulinemia of obese mice, since 
it is known that insulin increases HIF-1α mRNA in adi-
pocytes [8], or other different stimuli [46]. This could 
also be the reason for the increased HIF–1α expression 
observed in the postprandial condition in wild-type 
mice. However, HIF-1α expression did not change in the 
postprandial condition in obese mice. This could be the 
same as in another study in which a similar blood flow 
was found before and after a meal in obese people [10]. 
However, there is little information on the effect of the 
postprandial state on VAT hypoxia. With these results, 
we could hypothesize that VAT from morbidly obese 
subjects would be in a hypoxic status all day (in fasting 
and in feeding status). This could have important reper-
cussions on the pathways regulated by hypoxia in VAT, 
such as angiogenesis, cell proliferation, apoptosis, inflam-
mation and insulin resistance [7, 8, 16, 17, 47, 48].
In conclusion, the results of the study showed that the 
VAT of morbidly obese subjects had an increased level of 
HIF-1α, a marker of hypoxia, which is negatively associ-
ated with the expression of genes involved in acetyl-CoA 
and fatty acid synthesis. Another important finding was 
that feeding status was associated with an increase in the 
VAT HIF-1α levels in C57BL6J wild-type mice, with a 
high level in both, fasting and feeding status in C57BL6J 
ob/ob mice. These persistently high levels of HIF-1α in 
obesity could have important repercussions on the path-
ways regulated by HIF-1α in VAT. Our results showed 
that VAT explants in the presence of hypoxia had a 
coordinated expression in genes involved in de novo lipo-
genesis pathways.
Clinical perspectives
HIF-1α has been proposed to play a key role in the pro-
motion and maintenance of dietary obesity. Most of these 
studies were conducted in animals and in other tissues 
different to VAT. However, there is very little reported 
on the influence of hypoxia on de novo lipogenesis in 
human VAT. The VAT of morbidly obese subjects had an 
increased level of HIF-1α, a marker of hypoxia. Another 
important finding was that the postprandial status in 
C57BL6J wild-type mice was associated with an increase 
in HIF-1α in VAT, with a high level in both, fasting and 
feeding status in C57BL6J ob/ob mice. In conclusion, 
hypoxia alters the mRNA expression of genes involved 
in de novo lipogenesis in VAT. These findings involve 
VAT in the metabolic consequences and comorbidities of 
obesity.
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